Article
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Feb 2012
Sheng Wang-Huei, Hung Chien-Ching, Chang Sui-Yuan, Liu Chun-Jen, Chen Mao-Yuan, Hsieh Szu-Min, Kao Jia-Horng, Chen Pei-Jer, Chang Shan-Chwen
Abstract excerpt
BACKGROUND: The impact of hepatitis B virus (HBV) genotypes B and C on the clinical, immunologic, and virologic outcomes of human immunodeficiency virus (HIV)-infected patients with chronic HBV infection remains largely unknown. METHODS: Between January 1997 and December 2008, we enrolled 96 HIV-infected patients with HBV genotype B coinfection and 49 with genotype C coinfection; the patients were followed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.